386 related articles for article (PubMed ID: 31311176)
1. Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives.
Serrano-Sevilla I; Artiga Á; Mitchell SG; De Matteis L; de la Fuente JM
Molecules; 2019 Jul; 24(14):. PubMed ID: 31311176
[TBL] [Abstract][Full Text] [Related]
2. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.
Luo Y; Wang Q
Int J Biol Macromol; 2014 Mar; 64():353-67. PubMed ID: 24360899
[TBL] [Abstract][Full Text] [Related]
3. Lyophilisation and concentration of chitosan/siRNA polyplexes: Influence of buffer composition, oligonucleotide sequence, and hyaluronic acid coating.
Veilleux D; Gopalakrishna Panicker RK; Chevrier A; Biniecki K; Lavertu M; Buschmann MD
J Colloid Interface Sci; 2018 Feb; 512():335-345. PubMed ID: 29080529
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
5. Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery.
Raviña M; Cubillo E; Olmeda D; Novoa-Carballal R; Fernandez-Megia E; Riguera R; Sánchez A; Cano A; Alonso MJ
Pharm Res; 2010 Dec; 27(12):2544-55. PubMed ID: 20857179
[TBL] [Abstract][Full Text] [Related]
6. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
7. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
[TBL] [Abstract][Full Text] [Related]
8. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols.
Tie S; Tan M
J Agric Food Chem; 2022 Feb; 70(4):903-915. PubMed ID: 35072455
[TBL] [Abstract][Full Text] [Related]
9. Composite polysaccharide fibers prepared by electrospinning and coating.
Maeda N; Miao J; Simmons TJ; Dordick JS; Linhardt RJ
Carbohydr Polym; 2014 Feb; 102():950-5. PubMed ID: 24507368
[TBL] [Abstract][Full Text] [Related]
10. Chitosan and hyaluronic acid-based nanocarriers for advanced cancer therapy and intervention.
Rohtagi P; Garg U; Triveni ; Jain N; Pandey M; Amin MCIM; Gorain B; Kumar P
Biomater Adv; 2024 Feb; 157():213733. PubMed ID: 38118207
[TBL] [Abstract][Full Text] [Related]
11. Versatile Types of Polysaccharide-Based Drug Delivery Systems: From Strategic Design to Cancer Therapy.
Sun Y; Jing X; Ma X; Feng Y; Hu H
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271967
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid/chitosan multilayer coatings on neuronal implants for localized delivery of siRNA nanoplexes.
Hartmann H; Hossfeld S; Schlosshauer B; Mittnacht U; Pêgo AP; Dauner M; Doser M; Stoll D; Krastev R
J Control Release; 2013 Jun; 168(3):289-97. PubMed ID: 23562632
[TBL] [Abstract][Full Text] [Related]
13. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
[TBL] [Abstract][Full Text] [Related]
14. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
[TBL] [Abstract][Full Text] [Related]
15. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.
de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ
Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084
[TBL] [Abstract][Full Text] [Related]
16. Applications of Important Polysaccharides in Drug Delivery.
Huang G; Mei X; Xiao F; Chen X; Tang Q; Peng D
Curr Pharm Des; 2015; 21(25):3692-6. PubMed ID: 25578889
[TBL] [Abstract][Full Text] [Related]
17. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.
Tirella A; Kloc-Muniak K; Good L; Ridden J; Ashford M; Puri S; Tirelli N
Int J Pharm; 2019 Apr; 561():114-123. PubMed ID: 30822503
[TBL] [Abstract][Full Text] [Related]
18. Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis.
Noreen S; Ma JX; Saeed M; Pervaiz F; Hanif MF; Ahmed B; Farooq MI; Akram F; Safdar M; Madni A; Naveed M; Chang-Xing L
Drug Deliv Transl Res; 2022 Nov; 12(11):2649-2666. PubMed ID: 35499715
[TBL] [Abstract][Full Text] [Related]
19. Ternary polymeric nanoparticles for oral siRNA delivery.
Zhang J; He C; Tang C; Yin C
Pharm Res; 2013 May; 30(5):1228-39. PubMed ID: 23307349
[TBL] [Abstract][Full Text] [Related]
20. Polysaccharide-based Nanoparticles for Gene Delivery.
Huh MS; Lee EJ; Koo H; Yhee JY; Oh KS; Son S; Lee S; Kim SH; Kwon IC; Kim K
Top Curr Chem (Cham); 2017 Apr; 375(2):31. PubMed ID: 28251564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
